BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7306089)

  • 1. Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.
    Kirschke H; Shaw E
    Biochem Biophys Res Commun; 1981 Jul; 101(2):454-8. PubMed ID: 7306089
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15).
    Kirschke H; Schmidt I; Wiederanders B
    Biochem J; 1986 Dec; 240(2):455-9. PubMed ID: 3814093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species variants of cathepsin L and their immunological identification.
    Mason RW
    Biochem J; 1986 Nov; 240(1):285-8. PubMed ID: 2435279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variations amongst lysosomal cysteine proteinases.
    Kirschke H; Locnikar P; Turk V
    FEBS Lett; 1984 Aug; 174(1):123-7. PubMed ID: 6468652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat mammary gland in culture secretes a stable high molecular weight form of cathepsin L.
    Recklies AD; Mort JS
    Biochem Biophys Res Commun; 1985 Aug; 131(1):402-7. PubMed ID: 4038303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B and L activities in isolated osteoclasts.
    Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.
    Bednarski E; Lynch G
    J Neurochem; 1996 Nov; 67(5):1846-55. PubMed ID: 8863489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain.
    Shaw E; Mohanty S; Colic A; Stoka V; Turk V
    FEBS Lett; 1993 Nov; 334(3):340-2. PubMed ID: 8243643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B.
    Brömme D; Steinert A; Friebe S; Fittkau S; Wiederanders B; Kirschke H
    Biochem J; 1989 Dec; 264(2):475-81. PubMed ID: 2604727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labelling of cysteine proteinases in purified lysosomes.
    Wilcox D; Mason RW
    Biochem Soc Trans; 1989 Dec; 17(6):1080-1. PubMed ID: 2628091
    [No Abstract]   [Full Text] [Related]  

  • 13. The thiol proteinase inhibitors, Z-Phe-PheCHN2 and Z-Phe-AlaCHN2, inhibit lysosomal protein degradation in isolated rat hepatocytes.
    Grinde B
    Biochim Biophys Acta; 1983 May; 757(1):15-20. PubMed ID: 6188494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of human liver cathepsin L.
    Mason RW; Barrett AJ
    Prog Clin Biol Res; 1985; 180():217-9. PubMed ID: 4034541
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo inhibition of rat liver cathepsin L by epidermal proteinase inhibitor.
    Hibino T; Fukuyama K; Epstein WL
    Biochem Biophys Res Commun; 1980 Mar; 93(2):440-7. PubMed ID: 6248041
    [No Abstract]   [Full Text] [Related]  

  • 17. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
    Wikstrom P; Kirschke H; Stone S; Shaw E
    Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.
    Pagano M; Esnard F; Engler R; Gauthier F
    Biochem J; 1984 May; 220(1):147-55. PubMed ID: 6547604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.
    Xing R; Mason RW
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):667-73. PubMed ID: 9841879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP.
    Yamaguchi N; Chung SM; Shiroeda O; Koyama K; Imanishi J
    Cancer Res; 1990 Feb; 50(3):658-63. PubMed ID: 2297706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.